Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

v3.22.2.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Financial Designation, Predecessor and Successor [Fixed List] Successor Predecessor Successor Predecessor
OPERATING REVENUE:        
TOTAL OPERATING REVENUE $ 248,260,073 $ 156,185,955 $ 791,258,378 $ 452,070,338
OPERATING EXPENSES:        
Medical Expenses 254,776,548 161,328,123 788,045,718 458,333,145
Premium Deficiency Reserve (7,301,630) 1,600,000 (10,115,714) 4,600,000
Corporate, General and Administrative Expenses 37,862,737 20,433,538 117,560,549 53,883,267
Sales and Marketing Expenses 1,119,552 491,418 3,392,178 1,118,160
Goodwill Impairment 0   851,455,754  
Depreciation and Amortization 21,814,803 456,418 65,286,715 1,218,797
TOTAL OPERATING EXPENSES 308,272,010 184,309,497 1,815,625,200 519,153,369
OPERATING LOSS (60,011,937) (28,123,542) (1,024,366,822) (67,083,031)
OTHER INCOME (EXPENSES):        
Interest Expense, net (2,749,681) (2,529,133) (8,244,806) (7,023,187)
Mark-to-Market of Stock Warrants (2,567,423) (1,401,686) 3,386,394 (12,063,265)
TOTAL OTHER INCOME (EXPENSE) (5,317,104) (3,930,819) (4,858,412) (19,086,452)
LOSS BEFORE INCOME TAXES (65,329,041) (32,054,361) (1,029,225,234) (86,169,483)
PROVISION FOR INCOME TAXES     0 0
NET LOSS (65,329,041) (32,054,361) (1,029,225,234) (86,169,483)
LESS NET LOSS ATTRIBUTABLE TO REDEEMABLE NON-CONTROLLING INTERESTS (54,155,858)   (853,124,598)  
NET LOSS ATTRIBUTABLE TO CONTROLLING INTERESTS $ (11,173,183) $ (32,054,361) $ (176,100,636) $ (86,169,483)
NET LOSS PER SHARE (BASIC) $ (0.27) [1] $ (4.24) [1]
NET LOSS PER SHARE (DILUTED) $ (0.27) [1] $ (4.27) [1]
Capitated Revenue        
OPERATING REVENUE:        
TOTAL OPERATING REVENUE $ 243,988,004 $ 153,072,995 $ 780,775,285 $ 443,598,050
Other Patient Service Revenue        
OPERATING REVENUE:        
TOTAL OPERATING REVENUE $ 4,272,069 $ 3,112,960 $ 10,483,093 $ 8,472,288
[1] The Company analyzed the calculation of net loss per member unit for predecessor periods prior to the Business Combinations and determined that it resulted in values that would not be meaningful to the users of these consolidated financial statements. Therefore, net loss per member unit information has not been presented for predecessor periods prior to the Business Combinations on December 3, 2021.